Search for: "SCHERING-PLOUGH"
Results 241 - 260
of 404
Sort by Relevance
|
Sort by Date
1 May 2009, 8:25 am
SEC Investigating Schering-Plough Trades: The SEC is investigating trading of Schering-Plough shares ahead of the announcement of its merger with Merck & Co., people familiar with the matter said. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
3 Apr 2009, 7:23 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
30 Mar 2009, 3:00 am
Schering-Plough Animal Health Corporation v. [read post]
26 Mar 2009, 1:18 am
Supreme Court has flagged suits over use of Schering-Plough Corp.'s NuvaRing contraceptive device as a mass tort and has assigned the litigation to Superior Court Judge Jonathan Harris in Bergen County for centralized management. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
20 Mar 2009, 2:20 am
The column returns to honor two lawyers behind two of the biggest, and most significant, transactions so far this year--Cooley Godward's Richard Climan advised Gilead Sciences on its $1.4 billion acquisition of CV Therapeutics, while Fried Frank's David Shine represented Merck in its $41 billion merger with Schering-Plough. [read post]
19 Mar 2009, 2:18 pm
Subsidiary 1 will merge with and into Schering-Plough, paying its shareholders $10.50 in cash and 0.5767 of a share of Schering-Plough. [7] Finally, Merck will merge with subsidiary 2. [8] Each stock of Merck will be converted into a stock of Schering-Plough. [9] Thus, Merck will be a wholly-owned subsidiary of Schering-Plough, but Schering-Plough will take the name of Merck. [10] In other words, on paper a… [read post]
17 Mar 2009, 6:00 am
Schering-Plough shareholders file a class action; Kasowitz Benson will represent another wholesale magazine distributor; and plaintiffs piggyback on an FCA suit against Forest Labs. [read post]
16 Mar 2009, 6:30 am
” Merck and Schering-Plough did a friendly deal this week, though, that will include their Canadian operations. [read post]
14 Mar 2009, 5:13 am
This study was funded by Schering-Plough. [read post]
11 Mar 2009, 6:30 am
Merck filed the agreement for its acquisition of Schering-Plough with regulators on Tuesday. [read post]
10 Mar 2009, 10:26 am
Moreover, the Merck deal seems to depend on whether a reverse triangular merger can beat a control change clause in a Schering-Plough agreement... [read post]
10 Mar 2009, 9:10 am
If Johnson & Johnson - or anyone else, for that matter - is thinking about making a play for Schering-Plough, here's a number worth considering: $1.25 billion. [read post]
9 Mar 2009, 9:52 pm
Based on the March 6, 2009 closing price of Merck stock, Schering-Plough... [read post]
9 Mar 2009, 8:13 am
Merck's $41 billion acquisition of Schering-Plough was already generating controversy Monday morning, as analysts expressed concern that a side deal with Johnson & Johnson could bring complications. [read post]
9 Mar 2009, 6:20 am
Lawyers from Wachtell, Lipton represented Schering-Plough. [read post]
9 Mar 2009, 5:02 am
Yet ANOTHER $3.4 million -- for Schering-Plough CEO Hassan, Tonight.And 2009 proxy-and-pay season is just barely underway, here! [read post]
9 Mar 2009, 4:53 am
Schering purchase? [read post]
9 Mar 2009, 4:44 am
Those companies surveyed by Towers Perrin are: Merck, Abbott Laboratories, Amgen, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-LaRoche, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth.You'll notice that list contains 14 companies â€â [read post]
